Study: Beutler 2005, Blood
Hematologic differences between African-Americans and whites: the roles of iron deficiency and alpha-thalassemia on hemoglobin levels and mean corpuscular volume
Citation
Beutler E, West C (2005). Blood. PubMed id 15790781.
Cards that cite this study (4)
Each card gives its own wording for who was tested, how and what was found.
- Alpha-thalassaemia trait: small red cells that are not low iron Tier B moderate
B 1,491 African American and 31,005 white people with routine blood results and stored samples, about half men and half women (n=32496)
Retrospective analysis of laboratory data with DNA testing for the -3.7 kb alpha-thalassaemia deletion.
Haematocrit, haemoglobin, MCV, transferrin saturation and white cell count were lower in African Americans; ferritin was higher. The -3.7 kb alpha-thalassaemia deletion accounted for about one third of the haemoglobin difference; sickle trait and raised creatinine had no effect. Of women, 19.8% of African Americans and 5.3% of white women would be called anaemic; without iron-deficient or thalassaemic people the figures were 6.1% and 2.77% (men 17.7% and 7.6%, then 4.29% and 3.6%). The authors say the same reference standards do not apply to all ethnic groups.
As recorded in this card: Beutler E, West C (2005), Blood, [primary]
Note: US laboratory population, not a random community sample. Abstract read in full. The authors favour separate standards; whether to adopt them is contested.
- Haemoglobin and white cell ranges on your blood test Tier B moderate
B 1,491 African American and 31,005 white people with routine laboratory results, about half men and half women (n=32496)
Retrospective analysis of laboratory data, with alpha-thalassaemia DNA testing.
Haematocrit, haemoglobin, MCV, transferrin saturation and white cell count were lower in African Americans and ferritin higher. The -3.7 kb alpha-thalassaemia deletion accounted for about a third of the haemoglobin difference. With iron-deficient and thalassaemic people removed, the share classed anaemic was 6.1% against 2.77% in women and 4.29% against 3.6% in men.
As recorded in this card: Beutler E, West C (2005), Blood, [primary]
Note: US laboratory population; abstract read in full.
- Iron, heavy periods and fibroids Tier B moderate
B 1,491 African-American and 31,005 White laboratory subjects (n=32496)
Analysis of anonymised laboratory data on haemoglobin, MCV, transferrin saturation, ferritin and white cell count.
Haemoglobin, haematocrit and MCV were lower in African-Americans. Among all subjects 19.8% of African-American women would be classed as anaemic against 5.3% of White women; after removing iron-deficient and thalassaemic subjects the gap narrowed to 6.1% and 2.77%. The alpha-thalassaemia deletion explained about a third of the haemoglobin difference. The authors say the same reference standards do not apply to all ethnic groups.
As recorded in this card: Beutler E, West C (2005), Blood, [primary]
Note: Laboratory-referred samples, not a population survey. A good example of a measured variable (alpha-thalassaemia deletion) standing behind a race difference.
- Low haemoglobin, low or high white cells: causes, thresholds and pregnancy Tier B thin
B 1,491 African American and 31,005 white people with routine laboratory results, about half men and half women (n=32496)
Retrospective analysis of laboratory data, with alpha-thalassaemia DNA testing.
Haematocrit, haemoglobin, MCV, transferrin saturation and white cell count were lower in African Americans and ferritin higher. The -3.7 kb alpha-thalassaemia deletion accounted for about a third of the haemoglobin difference; sickle trait had no effect. Before iron deficiency and thalassaemia were removed, 19.8% of African American women and 5.3% of white women would have been classed anaemic; after, 6.1% and 2.77%. The authors say the same reference standards do not apply to all ethnic groups.
As recorded in this card: Beutler E, West C (2005), Blood, [primary]
Note: US laboratory population; abstract read in full.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.